Citations

Clear

6274 citation(s) found for "To, Andrew".

Rate of kidney function decline and factors predicting progression of kidney disease in type 2 diabetes mellitus patients with reduced kidney function: A nationwide retrospective cohort study
Kaewput, Wisit , Chewcharat, Api , Kaewput, Chalermrat , Suwannahitatorn, Picha , Cheungpasitporn, Wisit , Cato, Liam D. , Harrison, Andrew M. , Vaitla, Pradeep , Cheungpasitporn, Wisit , Harrison, Andrew Marc , Kaewput, Wisit , Chewcharat, Api , Thongprayoon, Charat , Rangsin, Ram , Satirapoj, Bancha , Mao, Michael A.

Mayo Clinic

Therapeutic Apheresis and Dialysis | January 30, 2020 | Volume: 24 | Issue: 6 | Pages: 677-687

10.1111/1744-9987.13480 | PMID 31997551 Get It

AbstractCurrently, the data on independent risk factors for the progression of kidney disease in type 2 diabetes mellitus (T2DM) patients with CKD are limited. This study aimed to investigate CKD progression in T2DM patients who have reduced kidney function with baseline estimated glomerular filtration rate (eGFRs) between 15 and 59 mL/min/1.73 m2. This study was composed of a nationwide retrospective cohort of adult T2DM patients from 831 public hospitals in Thailand during the year 2015. T2DM patients with CKD stages 3 and 4 were followed up, until development of CKD stage 5, requirement of chronic dialysis, loss to follow‐up, death, or 31 May 2018, whichever came first. Cox proportional hazard regression was utilized for analysis. A total of 8464 participants were included; 30.4% were male. The mean age was 69 ± 10 years. The mean eGFR was 45 ± 11 mL/min/1.73 m2. The incidence of CKD stage 5 or the need for chronic dialysis was 16.4 per 1000 person‐years. The annual rate of eGFR decline during a mean follow‐up of 29 months was −2.3 mL/min/1.73 m2; 14.4% had a rapid decline in eGFR. The risk factors associated with progression to CKD stage 5 or the need for chronic dialysis were diabetes duration, systolic blood pressure, serum uric acid, albuminuria, and baseline eGFR. Conversely, older age and the use of renin‐angiotensin aldosterone system blockade were associated with decreased risks for rapid CKD progression and incidence CKD stage 5 or dialysis. This study identifies multiple predictive risk factors that support a multifaceted approach to prevent progression of advanced CKD.
Appropriate cohort selection and its impact on a meta-analysis evaluating the efficacy of direct oral anticoagulants post-percutaneous coronary intervention
Agasthi, Pradyumna , Tseng, Andrew S. , Mulpuru, Siva K. , Tseng, Andrew , Tseng, A S

Mayo Clinic

European Heart Journal | January 27, 2020 | Volume: 41 | Issue: 17 | Pages: 1700-1700

10.1093/eurheartj/ehaa081 | PMID 32060537 Get It

Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question—Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head
Abrams, Ross A. , Winter, Kathryn, Safran, Howard , Regine, William F., Berger, Adam C. , Gillin, Michael T. , Lowy, Andrew M. , DiPetrillo, Thomas A., Corn, Benjamin W. , Seaward, Samantha A. , Haddock, Michael G. , Song, Suisui, Jiang, Yixing , Fisher, Barbara J., Mehta, Sharmila, Willett, Christopher G. , Crane, Christopher H. , Seaward, Samantha A , Goodman, Karyn A. , Philip, Philip A. , Wu, Abraham J , Katz, Alan W.

Mayo Clinic

American Journal of Clinical Oncology | January 27, 2020 | Volume: 43 | Issue: 3 | Pages: 173-179

10.1097/coc.0000000000000633 | PMID 31985516 Get It

Purpose: NRG/RTOG 0848 was designed to determine whether adjuvant radiation with fluoropyrimidine sensitization improved survival following gemcitabine-based adjuvant chemotherapy for patients with resected pancreatic head adenocarcinoma. In step 1 of this protocol, patients were randomized to adjuvant gemcitabine versus the combination of gemcitabine and erlotinib. This manuscript reports the final analysis of these step 1 data. Methods: Eligibility—within 10 weeks of curative intent pancreaticoduodenectomy with postoperative CA19-9<180. Gemcitabine arm—6 cycles of gemcitabine. Gemcitabine+erlotinib arm—gemcitabine and erlotinib 100 mg/d. Two hundred deaths provided 90% power (1-sided α=0.15) to detect the hypothesized OS signal (hazard ratio=0.72) in favor of the arm 2. Results: From November 17, 2009 to February 28, 2014, 163 patients were randomized and evaluable for arm 1 and 159 for arm 2. Median age was 63 (39 to 86) years. CA19-9 ≤90 in 93%. Arm 1: 32 patients (20%) grade 4 and 2 (1%) grade 5 adverse events; arm 2, 27 (17%) grade 4 and 3 (2%) grade 5. GI adverse events, arm 1: 22% grade ≥3 and arm 2: 28%, ( P =0.22). The median follow-up (surviving patients) was 42.5 months (min-max: <1 to 75). With 203 deaths, the median and 3-year OS (95% confidence interval) are 29.9 months (21.7, 33.4) and 39% (30, 45) for arm 1 and 28.1 months (20.7, 30.9) and 39% (31, 47) for arm 2 (log-rank P =0.62). Hazard ratio (95% confidence interval) comparing OS of arm 2 to arm 1 is 1.04 (0.79, 1.38). Conclusions: The addition of adjuvant erlotinib to gemcitabine did not provide a signal for increased OS in this trial.
An Investigation of Healthcare Worker Perception of Their Workplace Safety and Incidence of Injury
Aljabri, Duaa , Vaughn, Andrew I. S., Austin, Matthew, White, Launia J. , Li, Zhuo , Naessens, James M. , Spaulding, Aaron , Li, Zhuo , Vaughn, Andrew, White, Launia, Naessens, James , Spaulding, Aaron

Mayo Clinic

Workplace Health & Safety | January 26, 2020 | Volume: 68 | Issue: 5 | Pages: 214-225

10.1177/2165079919883293 | PMID 31983297 Get It

Background: Managing the safety climate in health care is a promising tool for improving employee and patient safety in the health care work environment. Gaps in the theoretical and conceptual underpinnings of safety climate, as well as the evidence base for its practical application in health care remain. The purpose of this study was to evaluate the number of work injuries occurring in health care work units and associated safety climate beliefs. Methods: A retrospective analysis was conducted utilizing organizational staff survey data collected by a large medical hospital in the Midwest in 2015. Employees ( n = 32,327) were invited to identify safety climate perceptions via survey. Injuries, days restricted, and days absent were identified through the Hospital’s Occupational Safety and Health Administration (OSHA) log. Zero inflated negative binomial regressions used injuries as dependent variables and safety climate perceptions as independent variables. Findings: In all, 23,599 employees completed the survey (73% response rate) across 1,805 employee work units which were defined as groupings of employees reporting to a single supervisor. We found that there was an association between fewer injuries and health care workers indicating that they share responsibility for compliance with safety rules and procedures (relative risk [RR] = 0.98, 95% confidence interval [CI] = [0.98, 0.99]). Conclusion/Application to Practice: This study supports the use of a safety climate measure to assess working units’ perceptions of employee safety. A continued focus on the health and safety of employees who interact directly with patients is warranted, as well as employees who do not provide direct patient care.
Piecewise exponential models with time‐varying effects: Estimating mortality after listing for solid organ transplant
Wey, Andrew , Salkowski, Nicholas , Kremers, Walter K. , Ahn, Yoon Son, Kremers, Walter K , Snyder, Jon J.

Mayo Clinic

Stat | January 24, 2020 | Volume: 9 | Issue: 1 | Pages: No page available

10.1002/sta4.264 Get It

Patient mortality after listing for a solid organ transplant is a relevant, patient‐centric metric, but risk factors for patient mortality after listing present severe non‐proportional hazards. We propose piecewise exponential models (PEMs) with time‐varying effects to account for the non‐proportional hazards, and we use the LASSO to minimize the risk of overfitting. We consider two parameterizations of a PEM: The first model has an overall effect in addition to the time‐varying effects (PEM‐TID), whereas the second model has only time‐varying effects (PEM‐TD). Because the LASSO can shrink every time‐varying effect to 0, risk factors in the PEM‐TID model can have proportional effects during follow‐up. In contrast, covariates in the PEM‐TD model must have different or no effects during follow‐up. These characteristics were illustrated for patients listed for liver transplant. The PEM‐TID model had similar or better predictive performance than the PEM‐TD model, and both were better than the Cox proportional hazards model. Thus, PEMs with time‐varying effects can improve predictive performance for patient mortality after listing for a solid organ transplant.
Fine‐Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt Synucleinopathies
Krohn, Lynne , Wu, Richard Y. J. , Heilbron, Karl , Ruskey, Jennifer A. , Laurent, Sandra B., Blauwendraat, Cornelis , Alam, Armaghan , Arnulf, Isabelle , Hu, Michele T.M., Dauvilliers, Yves , Högl, Birgit , Toft, Mathias , Bjørnarå, Kari Anne , Stefani, Ambra , Holzknecht, Evi , Monaca, Christelle, Abril, Beatriz, Young, Peter , Heidbreder, Anna , Mollenhauer, Brit , Sixel‐Döring, Friederike , Trenkwalder, Claudia , Šonka, Karel , Figorilli, Michela , Puligheddu, Monica , Dijkstra, Femke , Viaene, Mineke , Oertel, Wolfang, Toffoli, Marco , Gagnon, Jean‐François , Nalls, Mike A., Singleton, Andrew B., Désautels, Alex , Montplaisir, Jacques , Ross, Owen A. , Dupré, Nicolas , Postuma, Ronald B., Antelmi, Elena , Cochen De Cock, Valérie , Rouleau, Guy Armand , Gan-Or, Ziv , Ross, Owen A , Dauvilliers, Yves , Stefani, Ambra , Toft, Mathias , Arnulf, Isabelle , Högl, Birgit , Sonka, Karel , Figorilli, Michela , Puligheddu, Monica , Heidbreder, Anna , Plazzi, Giuseppe , Antelmi, Elena , Ferini-Strambi, Luigi , Kemlink, David , Gigli, Gian Luigi , Valente, Mariarosaria , Singleton, Andrew , Cannon, Paul, Boeve, Bradley F. , Fon, Edward A , Postuma, Ronald B. , Pihlstrøm, Lasse , Gan‐Or, Ziv

Mayo Clinic

Annals of Neurology | January 24, 2020 | Volume: 87 | Issue: 4 | Pages: 584-598

10.1002/ana.25687 | PMID 31976583 Get It

Objective Rapid eye movement sleep behavior disorder (RBD) is a prodromal synucleinopathy, as >80% will eventually convert to overt synucleinopathy. We performed an in‐depth analysis of the SNCA locus to identify RBD‐specific risk variants. Methods Full sequencing and genotyping of SNCA was performed in isolated/idiopathic RBD (iRBD, n = 1,076), Parkinson disease (PD, n = 1,013), dementia with Lewy bodies (DLB, n = 415), and control subjects (n = 6,155). The iRBD cases were diagnosed with RBD prior to neurodegeneration, although some have since converted. A replication cohort from 23andMe of PD patients with probable RBD (pRBD) was also analyzed (n = 1,782 cases; n = 131,250 controls). Adjusted logistic regression models and meta‐analyses were performed. Effects on conversion rate were analyzed in 432 RBD patients with available data using Kaplan–Meier survival analysis. Results A 5′‐region SNCA variant (rs10005233) was associated with iRBD (odds ratio [OR] = 1.43, p = 1.1E‐08), which was replicated in pRBD. This variant is in linkage disequilibrium (LD) with other 5′ risk variants across the different synucleinopathies. An independent iRBD‐specific suggestive association (rs11732740) was detected at the 3′ of SNCA (OR = 1.32, p = 4.7E‐04, not statistically significant after Bonferroni correction). Homozygous carriers of both iRBD‐specific SNPs were at highly increased risk for iRBD (OR = 5.74, p = 2E‐06). The known top PD‐associated variant (3′ variant rs356182) had an opposite direction of effect in iRBD compared to PD. Interpretation There is a distinct pattern of association at the SNCA locus in RBD as compared to PD, with an opposite direction of effect at the 3′ of SNCA . Several 5′ SNCA variants are associated with iRBD and with pRBD in overt synucleinopathies. ANN NEUROL 2020;87:584–598
Kidney Structural Features from Living Donors Predict Graft Failure in the Recipient
Issa, Naim , Lopez, Camden , Đenić, Aleksandar , Taler, Sandra J. , Larson, Joseph J. , Kremers, Walter K. , Ricaurte, Luisa , Merzkani, Massini , Alexander, Mariam P., Chakkera, Harini A. , Stegall, Mark D. , Augustine, Joshua J. , Alexander, Mariam Priya, Rule, Andrew D , Stegall, Mark D , Denic, Aleksandar , Lopez, Camden L , Chakkera, Harini A , Kremers, Walter K , Augustine, Joshua , Rule, Andrew D.

Mayo Clinic

Journal of the American Society of Nephrology | January 23, 2020 | Volume: 31 | Issue: 2 | Pages: 415-423

10.1681/asn.2019090964 | PMID 31974271 Get It

Significance Statement The quality of a kidney obtained from a living donor is often inferred from the donor’s age, risk factors, and kidney function. Little is known about the influence of a donated kidney’s structural features on the risk of death-censored graft failure in the recipient. In an analysis of 2293 kidney donor-recipient pairs, the authors identified subclinical nephrosclerosis, larger nephron size (but not nephron number), and smaller medullary volume as structural predictors of death-censored graft failure that were independent of both donor and recipient clinical characteristics. These findings provide important insights into the factors that define the “intrinsic quality” of the living kidney donor graft at the time of donation, and support use of intraoperative biopsies to identify donor kidneys that are at higher risk for failure. Background Nephrosclerosis, nephron size, and nephron number vary among kidneys transplanted from living donors. However, whether these structural features predict kidney transplant recipient outcomes is unclear. Methods Our study used computed tomography (CT) and implantation biopsy to investigate donated kidney features as predictors of death-censored graft failure at three transplant centers participating in the Aging Kidney Anatomy study. We used global glomerulosclerosis, interstitial fibrosis/tubular atrophy, artery luminal stenosis, and arteriolar hyalinosis to measure nephrosclerosis; mean glomerular volume, cortex volume per glomerulus, and mean cross-sectional tubular area to measure nephron size; and calculations from CT cortical volume and glomerular density on biopsy to assess nephron number. We also determined the death-censored risk of graft failure with each structural feature after adjusting for the predictive clinical characteristics of donor and recipient. Results The analysis involved 2293 donor-recipient pairs. Mean recipient follow-up was 6.3 years, during which 287 death-censored graft failures and 424 deaths occurred. Factors that predicted death-censored graft failure independent of both donor and recipient clinical characteristics included interstitial fibrosis/tubular atrophy, larger cortical nephron size (but not nephron number), and smaller medullary volume. In a subset with 12 biopsy section slides, arteriolar hyalinosis also predicted death-censored graft failure. Conclusions Subclinical nephrosclerosis, larger cortical nephron size, and smaller medullary volume in healthy donors modestly predict death-censored graft failure in the recipient, independent of donor or recipient clinical characteristics. These findings provide insights into a graft’s “intrinsic quality” at the time of donation, and further support the use of intraoperative biopsies to identify kidney grafts that are at higher risk for failure.
Benign Vocal Fold Lesions in Patients with Chronic Cough
Adessa, Michelle , Xiao, Roy , Hull, Darcey, Milstein, Claudio F. , Benninger, Michael S. , Bryson, Paul C. , Bowen, Andrew J.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | January 21, 2020 | Volume: 162 | Issue: 3 | Pages: 322-325

10.1177/0194599819900505 | PMID 31959050 Get It

ObjectiveThe objective of this study was to determine the prevalence of benign vocal fold lesions (BVFLs) in patients with chronic cough over a 1‐year period.Study DesignCase series with chart review.SettingTertiary academic medical center.Subjects and MethodsA retrospective cohort study of patients with chronic cough seen in our tertiary multidisciplinary cough clinic from 2016 to 2017 was conducted. Patient characteristics, presence of BVFLs by laryngoscopy, and Leicester Cough Questionnaire (LCQ) were recorded.ResultsA total of 419 patients were included (average age: 61 years), and 67% of patients were female. Ten percent of patients had BVFLs: granuloma (5%), leukoplakia (3%), nodules (2%), and polyps (1%). Median cough duration was 2.9 years (interquartile range [IQR], 0.7‐8.5); no significant difference in median cough duration was observed between patients with BVFLs and those with no lesions (2.6 vs 3.0 years, P =. 86). In total, 178 patients (42%) had available LCQ data: median score of 10.2 (IQR, 7.9‐13.9); no significant difference in median LCQ was observed between patients with BVFLs and those with no lesions (10.5 vs 10.1, P =. 54).ConclusionPrevalence of BVFLs in our cohort of patients with chronic cough was 10%, with posterior glottic lesions—granuloma—being the most common (5%). Prevalence of midmembranous lesions was as follows: vocal fold nodules (2%) and vocal fold polyps (1%). BVFLs were not associated with longer cough duration or more severe cough. We cannot determine a causative or noncausative relationship between BVFLs and chronic cough at this time due to lack of a control group.
Autoimmune Vestibulocerebellar Syndromes
Narayan, Ram , Fife, Terry D., McKeon, Andrew

Mayo Clinic

Seminars in Neurology | January 21, 2020 | Volume: 40 | Issue: 01 | Pages: 097-115

10.1055/s-0039-3402061 | PMID 31958862 Get It

AbstractAutoimmune disorders affecting the vestibular end organs, vestibular pathways, vestibular nuclei, and vestibulocerebellum are often underrecognized as a cause of chronic dizziness and ataxia. Autoantibodies specific for cell-surface, synaptic, and intracellular neural antigens serve as biomarkers of these disorders. This article describes the epidemiology, clinical presentation, diagnostic considerations, imaging findings, treatment, and prognosis of autoimmune disorders, in which the vestibulocerebellar syndrome is the main or presenting clinical presentation. Antibodies specific for intracellular antigenic targets described in the article are PCA-1 (Purkinje cell cytoplasmic antibody type 1, also known as anti-Yo), ANNA-1 (antinuclear neuronal antibody type 1, also known as anti-Hu), ANNA-2 (antinuclear neuronal antibody type 2, also known as anti-Ri), Ma1/2 (anti-Kelch-like 11/12 antibody), Kelch-like 11, amphiphysin, CV2 (collapsin response 2, also known as collapsin response mediator protein-5 [CRMP5]), VGCC (voltage-gated calcium channel), GAD65 (glutamic acid decarboxylase 65-kDa isoform), AP3B2 (adaptor protein 3B2, also known as anti-Nb), MAP1B (microtubule-associated protein 1B antibody, also known as anti-PCA-2), and neurochondrin antibodies. Antibodies targeting cell-surface or synaptic antigenic targets described in the article include DNER (delta/notchlike epidermal growth factor related receptor; antigen to anti-Tr), CASPR2 (contactin-associated proteinlike 2), septin-5, Homer-3, and mGluR1 (metabotropic glutamate receptor 1). The vestibulocerebellar presentation is largely indistinguishable among these conditions and is characterized by subacute onset of cerebellar symptoms over weeks to months. The diagnosis of autoimmune vestibulocerebellar syndromes is based on a combination of clinical and serological features, with a limited role for neuroimaging. Subtle eye movement abnormalities can be an early feature in many of these disorders, and therefore a meticulous vestibulo-ocular examination is essential for early and correct identification. Cancer occurrence and its type are variable and depend on the autoantibody detected and other cancer risk factors. Treatment comprises immunotherapy and cancer-directed therapy. Acute immunotherapies such as intravenous immunoglobulin, plasma exchange, and steroids are used in the initial phase, and the use of long-term immunosuppression such as rituximab may be necessary in relapsing cases. Outcomes are better if immunotherapy is started early. The neurologic prognosis depends on multiple factors.